Loading...
IL-2 administration increases CD4(+)CD25(hi) Foxp3(+) regulatory T cells in cancer patients
Interleukin-2 (IL-2) is historically known as a T-cell growth factor. Accumulating evidence from knockout mice suggests that IL-2 is crucial for the homeostasis and function of CD4(+)CD25(+) regulatory T cells in vivo. However, the impact of administered IL-2 in an immune intact host has not been st...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The American Society of Hematology
2006
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1473973/ https://ncbi.nlm.nih.gov/pubmed/16304057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-06-2399 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|